Cargando…
OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal Hypertension
PURPOSE: Management of decompensated cirrhosis may include the use of vasoconstrictors that can lead to serious adverse events. OCE-205 was designed as a highly selective V1a receptor partial agonist, intended to have a wider therapeutic window than full vasopressin agonists. METHODS: We aimed to ch...
Autores principales: | Bukofzer, Stan, Harris, Geoffrey, Song, Susan, Cable, Edward E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352125/ https://www.ncbi.nlm.nih.gov/pubmed/37469992 http://dx.doi.org/10.2147/JEP.S416673 |
Ejemplares similares
-
OCE-205 in rats and non-human primates: Pharmacokinetic and pharmacodynamic analysis
por: Bukofzer, Stan, et al.
Publicado: (2023) -
OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers
por: Bagger, Yu, et al.
Publicado: (2023) -
The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023) -
Endoscopic ultrasound-guided portal pressure gradient measurement in managing portal hypertension
por: Lesmana, Cosmas Rinaldi Adithya
Publicado: (2023) -
Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
por: Yao, Hongjuan, et al.
Publicado: (2020)